Patents by Inventor Brian Edward Collins

Brian Edward Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10377809
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 13, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Patent number: 10266590
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: April 23, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Publication number: 20190077857
    Abstract: The present invention relates to the characterization and production of adalimumab.
    Type: Application
    Filed: May 9, 2018
    Publication date: March 14, 2019
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20190079101
    Abstract: Methods of making and evaluating biologic therapeutic products are disclosed.
    Type: Application
    Filed: April 9, 2018
    Publication date: March 14, 2019
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Patent number: 9921210
    Abstract: Methods and compositions related to high mannose glycans are described.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: March 20, 2018
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Jay Duffner, Carlos J. Bosques, Dorota A. Bulik, James Myette, James Meador
  • Patent number: 9890410
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: February 13, 2018
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nathaniel Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian Edward Collins
  • Publication number: 20170247426
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: April 10, 2017
    Publication date: August 31, 2017
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Publication number: 20170233782
    Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using ammonium and/or lysine, are described.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 17, 2017
    Inventors: Brian Edward Collins, Holly Prentice, Brett Belongia, Rasheed Tijani
  • Patent number: 9695244
    Abstract: The present invention relates to the characterization and production of denosumab.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: July 4, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Patent number: 9677105
    Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using ammonium and/or lysine, are described.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: June 13, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Holly Prentice, Brett Belongia, Rasheed Tijani
  • Publication number: 20170152319
    Abstract: The present invention relates to the characterization and production of biosimilars.
    Type: Application
    Filed: September 1, 2016
    Publication date: June 1, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Patent number: 9650433
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: May 16, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Publication number: 20170074890
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Publication number: 20160097074
    Abstract: The invention provides methods, databases and systems for making glycoprotein products having defined properties.
    Type: Application
    Filed: October 14, 2015
    Publication date: April 7, 2016
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Dorota A. Bulik, Ian C. Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Kaundinya
  • Publication number: 20160060675
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 3, 2016
    Inventors: Nathaniel Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian Edward Collins
  • Publication number: 20150246974
    Abstract: The present invention relates to the characterization and production of denosumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: September 3, 2015
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150204884
    Abstract: Methods of making and evaluating antibody biological therapeutics (biosimilars) for adalimumab, rituximab and panitumumab are disclosed.
    Type: Application
    Filed: May 31, 2013
    Publication date: July 23, 2015
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150158943
    Abstract: Production and bioanalytical characterization of determinative parameters of adalimumab is presented.
    Type: Application
    Filed: May 31, 2013
    Publication date: June 11, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150152184
    Abstract: The present invention relates to the characterization and production of panitumumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: June 4, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150147317
    Abstract: The present invention relates to the characterization and production of bevacizumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 28, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques